DOI:
10.1055/s-00035026
Applied Clinical Informatics
LinksSchließen
Referenz
Gilead Sciences Inc.
U.S. Food and Drug Administration Approves Expanded Indication for Truvada® (Emtricitabine and Tenofovir Disoproxil Fumarate) for Reducing the Risk of Acquiring HIV-1 in Adolescents.
Published 2018. Accessed September 15, 2021 at:
https://www.gilead.com/news-and-press/press-room/press-releases/2018/5/us-food-and-drug-administration-approves-expanded-indication-for-truvada-emtricitabine-and-tenofovir-disoproxil-fumarate-for-reducing-the-risk-of
Für die Inhalte der Internetseiten anderer Anbieter übernehmen wir keine Verantwortung.